Volke, Vallo
Katus, Urmeli
Johannson, Annika
Toompere, Karolin
Heinla, Keiu
Rünkorg, Kertu
Uusküla, Anneli
Funding for this research was provided by:
Estonian Ministry of Education and Research (IUT34-17, IUT34-17, IUT34-17, IUT34-17)
Article History
Received: 2 June 2021
Accepted: 27 September 2022
First Online: 19 October 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: Vallo Volke has served at speakers’ bureau and received travel grants from Novo Nordisk; Eli Lilly; Aventis, Astra Zeneca and Boehringer Ingelheim. The remaining authors have declared that no conflict of interest exists.